Findings
Researchers face challenges in scientific methodology, regulatory, legal, and operational aspects.
Many consumer-grade devices lack scientific evidence for their health claims.
There are significant challenges in data management, infrastructure, analysis, and security.
Lack of mobile technology data standards and transparency in data processing algorithms.
The need for a shared understanding of methodologies and terminology.

Recommendations
Develop industry-wide standards for data and terminology.
Foster dialogue between biopharmaceutical industry and device manufacturers for methodological development.
Ensure a patient-centric approach in clinical trials using wearable devices.
Conduct well-powered studies with clear medical problem statements.
Implement rigorous analytical and clinical validation processes.

Regulatory Considerations
Separate marketing approval paths for drugs and devices in the US.
Most wearable devices are classified as Class II devices requiring 510(k) clearance.
Compliance with HIPAA for data obtained via medical devices.
Need for device performance validation in specific populations relevant to device label claims.
Differences in US and EU regulations regarding data protection and consent requirements.